Lukas Hainz

We are joined today by Ivan Kairatov, a biopharma expert with deep insights into the technological innovations shaping the future of medicine. We will be exploring the recent expansion of a groundbreaking protein discovery platform into Asia, discussing its installation at two leading Taiwanese

The ability to track cancer's genetic secrets through a simple blood draw is no longer a futuristic concept but a clinical reality facing its own set of critical challenges. For years, the field of oncology has been steadily moving away from invasive tissue biopsies toward liquid biopsies, a

A conservative West Virginia lawmaker and a progressive California governor rarely find common ground, yet they have become improbable allies in a sweeping national movement to fundamentally reshape what Americans eat and how public health is managed. This decentralized but powerful crusade,

For the millions of people living with the relentless progression of Parkinson's disease, the daily battle for motor control has long been fought with a limited and often burdensome arsenal of treatments. The landscape of this fight is on the cusp of a dramatic transformation, however, as two

The dream of long-duration missions to the Moon and Mars carries with it a harsh physiological reality: the human body, evolved for Earth's gravity, deteriorates alarmingly in space. Prolonged exposure to microgravity triggers a cascade of deconditioning effects, including severe muscle atrophy,

A recent international study is fundamentally changing the way clinicians understand and diagnose hereditary colorectal cancer, revealing that a direct analysis of colorectal polyp DNA can uncover critical information that standard blood tests frequently overlook. This groundbreaking research, a

A landmark clinical analysis has provided compelling evidence that the future of oncology may be found within the very code that fuels the disease, demonstrating that treatments personalized to a tumor's unique genetic profile can dramatically improve patient outcomes. This pivotal research

The silent pandemic of antibiotic resistance, a threat the World Health Organization has elevated to one of the greatest dangers to modern medicine, has an unexpected and pervasive accomplice in the fields and farms that feed the world. A primary pathway for this threat originates in livestock

The development of new medicines for the most critically ill patients is a path fraught with immense challenges, where promising breakthroughs can be abruptly overshadowed by unforeseen safety concerns. In a significant and unexpected development, London-based biopharmaceutical company Pulmocide

A landmark French study involving over 100,000 adults has brought renewed scrutiny to the grocery aisle, suggesting a significant association between higher dietary exposure to specific food preservatives and a modestly increased incidence of cancer. The research, published in The BMJ , leverages